Adherium Ltd. · ASX:ADR

Adherium — AusBiotech 2016

4 slides from Adherium's conference presentation, Oct 26, 2016

  1. Slide 1: Adherium AusBiotech Presentation, 26 October 2016

    Adherium® AusBiotech Presentation 26 October 2016

  2. Slide 2: Investment Highlights

    INVESTMENT HIGHLIGHTS Adherium provides valuable exposure to the rapidly growing digital health sector  Commercialisation stage digital health company with a clear path to profitability  Valuable intellectual property portfolio, with a 15 year investment in one of the world’s largest databases of

  3. Slide 3: Positioning Adherium for Commercialisation

    POSITIONING ADHERIUM FOR COMMERCIALISATION Adherium is now well positioned for rapid commercialisation and growth Future milestones  Negotiate and sign agreement with leading global distributor partner Payor/provider roll-out  Sign full contract with US hospital network and fully integrate SmartIn

  4. Slide 4: Disclaimer and Forward Looking Statements

    DISCLAIMER AND FORWARD LOOKING STATEMENTS The following material is of a general nature and has only been prepared as a presentation aid. This presentation does NOT contain all of the information that may be required for evaluating Adherium Limited ACN 605 352 510 (Adherium® ), its assets, prospects

Adherium — AusBiotech 2016 on 6ix